Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/3935
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
IXEMPRA (Kit)
|
| dailymed-instance:activeIng... | |
| dailymed-instance:boxedWarn... |
WARNING: TOXICITY IN HEPATIC IMPAIRMENT: IXEMPRA in combination with capecitabine is contraindicated in patients with AST or ALT>2.5 x ULN or bilirubin>1 x ULN due to increased risk of toxicity and neutropenia-related death [see Contraindications (4) and Warnings and Precautions (5.3)].
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:genericMe... |
ixabepilone
|
| dailymed-instance:fullName |
IXEMPRA (Kit)
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
IXEMPRA
|